Cargando…

Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment

Detalles Bibliográficos
Autores principales: Kansy, Benjamin A, Lin, Yan, Ding, Fei, Gibson, Sandra Poveda, Jie, Hyun-Bae, Ferris, Robert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646103/
http://dx.doi.org/10.1186/2051-1426-3-S2-P73
_version_ 1782400915077070848
author Kansy, Benjamin A
Lin, Yan
Ding, Fei
Gibson, Sandra Poveda
Jie, Hyun-Bae
Ferris, Robert L
author_facet Kansy, Benjamin A
Lin, Yan
Ding, Fei
Gibson, Sandra Poveda
Jie, Hyun-Bae
Ferris, Robert L
author_sort Kansy, Benjamin A
collection PubMed
description
format Online
Article
Text
id pubmed-4646103
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46461032015-11-20 Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment Kansy, Benjamin A Lin, Yan Ding, Fei Gibson, Sandra Poveda Jie, Hyun-Bae Ferris, Robert L J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646103/ http://dx.doi.org/10.1186/2051-1426-3-S2-P73 Text en Copyright © 2015 Kansy et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Kansy, Benjamin A
Lin, Yan
Ding, Fei
Gibson, Sandra Poveda
Jie, Hyun-Bae
Ferris, Robert L
Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title_full Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title_fullStr Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title_full_unstemmed Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title_short Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
title_sort anti-egfr mab cetuximab therapy increases t cell receptor (tcr) diversity in the peripheral blood and focuses tcr richness in the tumor microenvironment
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646103/
http://dx.doi.org/10.1186/2051-1426-3-S2-P73
work_keys_str_mv AT kansybenjamina antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment
AT linyan antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment
AT dingfei antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment
AT gibsonsandrapoveda antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment
AT jiehyunbae antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment
AT ferrisrobertl antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment